OBJECTIVE: Intrauterine growth restriction (IUGR) is a condition in which the fetus fails to achieve its full growth potential. There are various etiologies for IUGR including placental factors, infections, maternal chronic conditions and genetic causes. We aimed to evaluate the yield of Chromosomal Microarray Analysis in different clinical scenarios as well as in pregnancies in which short lone bones were the major finding. STUDY DESIGN: Our cohort included 246 cases of pregnancies. In 182 cases IUGR was the prominent feature while in 64 cases fetal short long bones were the prominent feature. CMA analysis was performed for all cases between January 2016 to March 2018. Data were retrieved from the Israeli national database and from patient medical records. In 130 cases data regarding the clinical and familial background and prenatal work-up performed during the pregnancy were available for sub analysis. Data collection is ongoing RESULTS: The mean gestational age at diagnosis was 31.5AE 9.4 weeks. The mean measured percentile was 3.8 AE 2.4. In 14 out of 246 cases (5.7%) CMA result was pathogenic/likely pathogenic. In 3 cases (1.2%) a microdeletion/duplication with low penetrance was detected and in 23 cases (9.3%) variables of unknown clinical significance were detected. There were 2 cases of trisomy 18, one case of trisomy 21, one case of triploidy and 10 cases of microdeletions/ microduplications 5 of which were detectable by karyotype. In pregnancies in which short long bones were the prominent finding, CMA was positive in 4 cases (6.25% ). In IUGR only cases there were 10 pathological CMA results (5.5%). The yield of CMA was significantly higher for cases with pathological echocardiogram (p¼0.003).And was close to reaching clinical significance for IUGR pregnancies, in which the lowest measured percentile was below 1 (p¼0.057). There was no significant difference for other parameters such as maternal illness, familial background of genetic conditions, obstetrics history, and prenatal work-up. CONCLUSION: The yield of CMA for IUGR is 5.7% and is higher in cases with pathological echocardiogram results and in pregnancies in which measured percentiles were below the 1. Other parameters did not reach clinical significance; however, data collection is ongoing, hence the power of such analysis will improve and may reflect additional contributing parameters. The incremental yield of CMA over karyotyping in our cohort karyotype was 64.28%.
895 Impact of twenty-week abortion bans in the setting of advances in prenatal diagnoses: costeffectiveness analysis OBJECTIVE: SMFM and ACOG guidelines recommend comprehensive prenatal diagnosis in pregnancy. Upon detection of structural abnormalities during the anatomic ultrasound, it is recommended that women undergo counseling including the opportunity for additional diagnostic testing including chromosomal microarray analysis (CMA). With the added prognostic value of a significant CMA abnormality, some women may desire pregnancy termination.
However, twenty states have enacted laws prohibiting abortion beyond 20 weeks' gestation; currently 17 are active. We sought to estimate the effect of 20-week abortion bans on health outcomes and costs in the setting of a fetal diagnosis from microarray with an underlying structural anomaly. STUDY DESIGN: A decision-analytic model was built using TreeAge software to evaluate the impact of a 20-week ban on abortion in a theoretical cohort of 10,000 women with abnormal CMA after identification of structural abnormalities on ultrasound. Outcomes included number of abortions, maternal death, neonatal death, intrauterine fetal demise, and a child with moderate or severe chromosomal microdeletions, in addition to cost and quality-adjustedlife-years (QALY). The threshold for cost-effectiveness was set to $100,000 per QALY. Sensitivity analyses were performed broadly. RESULTS: In this hypothetical cohort, a 20-week abortion ban results in an additional 217 stillbirths, 337 neonatal deaths. There would be 1,823 fewer terminations of pregnancy. The presence of a ban results in 48,148 fewer maternal QALYs and costs society over $3.3 billion. Among the 5,958 women who would consider termination, 1,650 would still travel out of state to obtain the abortion. In sensitivity analyses, not having a ban in place remained the cost-effective strategy until abortion cost over 920 times its current cost. CONCLUSION: Policies prohibiting termination of pregnancy after 20 weeks' gestation are associated with significant societal costs and worsened maternal outcomes when considering a population of women with abnormal ultrasound and CMA. With increased utilization and improved resolution of CMA testing, the magnitude of this impact may increase.
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